This training has no registration dates yet
2.5-hour Webinar
Originally aired May 7, 2025
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Webinar Materials: https://tiny.ucsf.edu/uP3oTs
Description: This 3-session webinar series highlights lectures from The 2025 Annual TB Conference. This webinar focuses on the following lectures presented during the Reframing Directly Observed Treatment (DOT) session:
- Survivor's Perspective - Nicole Skaggs
- Historical Perspective on DOT - E. Jane Carter, MD
- Adherence and Clinical Outcomes: What Does This Mean for DOTs and DATs - Helen Stagg, PhD
- TB vs HIV - Treatment Support and Supervision - Amrita Daftary, PhD
- DOT, Human Rights, and Ethics - Jonathan Stillo, PhD
You may also view the first webinar session recording, The Riddle of TB Drug Resistance, or the second webinar session recording, What is Hot in Treatment Differentiation and Individualization.
YouTube Link: https://www.youtube.com/watch?v=3o8MNlHH3Pw
*CME and CE units are not being offered for this recording, and there is no participant evaluation.
Presenters:
Nicole Skaggs
TB Survivor
We Are TB
E. Jane Carter, MD
Professor Emerita, Medicine
Brown University
Providence, RI
Helen Stagg, PhD
Professor, Infectious Disease Epidemiology
London School of Hygiene & Tropical Medicine
London, UK
Amrita Daftary, PhD
Associate Professor
School of Global Health
York University
Toronto, ON, Canada
Jonathan Stillo, PhD
Associate Professor, Cultural Anthropology
Undergraduate Program Director
Wayne State University
Detroit, MI
Moderators:
E. Jane Carter, MD
Professor Emerita, Medicine
Brown University
Providence, RI
James 'Jay' Johnston, MD, MPH, FRCPC
President, The Union-North America Region
Clinical Professor, Medicine
University of British Columbia
Vancouver, Canada
Kevin Schwartzman, MD, MPH
Professor and Associate Chair for Research
Department of Medicine
McGill University
Montreal, QB, Canada
United States